Short-term molecular consequences of chromosome mis-segregation for genome stability.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 03 2023
Historique:
received: 15 07 2022
accepted: 01 03 2023
entrez: 11 3 2023
pubmed: 13 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Chromosome instability (CIN) is the most common form of genome instability and is a hallmark of cancer. CIN invariably leads to aneuploidy, a state of karyotype imbalance. Here, we show that aneuploidy can also trigger CIN. We found that aneuploid cells experience DNA replication stress in their first S-phase and precipitate in a state of continuous CIN. This generates a repertoire of genetically diverse cells with structural chromosomal abnormalities that can either continue proliferating or stop dividing. Cycling aneuploid cells display lower karyotype complexity compared to the arrested ones and increased expression of DNA repair signatures. Interestingly, the same signatures are upregulated in highly-proliferative cancer cells, which might enable them to proliferate despite the disadvantage conferred by aneuploidy-induced CIN. Altogether, our study reveals the short-term origins of CIN following aneuploidy and indicates the aneuploid state of cancer cells as a point mutation-independent source of genome instability, providing an explanation for aneuploidy occurrence in tumors.

Identifiants

pubmed: 36906648
doi: 10.1038/s41467-023-37095-7
pii: 10.1038/s41467-023-37095-7
pmc: PMC10008630
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1353

Informations de copyright

© 2023. The Author(s).

Références

Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Cytometry A. 2011 Dec;79(12):1016-22
pubmed: 22052612
Cell. 2008 Feb 8;132(3):487-98
pubmed: 18267078
Cell. 2013 Nov 7;155(4):948-62
pubmed: 24183448
Nucleic Acids Res. 2020 Jan 8;48(D1):D682-D688
pubmed: 31691826
EMBO J. 2013 Oct 16;32(20):2661-71
pubmed: 24065128
Cell. 2012 Jan 20;148(1-2):112-25
pubmed: 22265406
Nat Commun. 2016 Feb 15;7:10754
pubmed: 26876972
Genes Dev. 2021 Aug 1;35(15-16):1093-1108
pubmed: 34266887
Nat Commun. 2019 Aug 8;10(1):3585
pubmed: 31395887
Genome Biol. 2016 May 31;17(1):115
pubmed: 27246460
Nat Rev Mol Cell Biol. 2015 Aug;16(8):473-85
pubmed: 26204159
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nat Rev Cancer. 2008 Dec;8(12):957-67
pubmed: 19005492
Nat Genet. 2006 May;38(5):500-1
pubmed: 16642009
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30566-30576
pubmed: 33203674
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Rev Genet. 2020 Jan;21(1):44-62
pubmed: 31548659
Nat Protoc. 2022 Jun;17(6):1444-1467
pubmed: 35396546
Nature. 2007 Jan 18;445(7125):328-32
pubmed: 17167415
Genome Res. 2015 Jun;25(6):918-25
pubmed: 25883319
Genes Dev. 2010 Jun 15;24(12):1208-19
pubmed: 20551170
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16527-16536
pubmed: 32601218
PLoS Genet. 2017 Aug 14;13(8):e1006958
pubmed: 28806726
Nat Commun. 2018 Jul 19;9(1):2834
pubmed: 30026603
Science. 2008 Oct 31;322(5902):703-9
pubmed: 18974345
PLoS Biol. 2003 Nov;1(2):E33
pubmed: 14624239
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Nat Cell Biol. 2009 Jun;11(6):753-60
pubmed: 19465922
Nature. 2021 Feb;590(7846):486-491
pubmed: 33505028
Mutat Res. 1985 Feb-Apr;147(1-2):29-36
pubmed: 3974610
Mol Syst Biol. 2012;8:608
pubmed: 22968442
Sci Adv. 2019 May 22;5(5):eaav3660
pubmed: 31131319
Genes Dev. 2007 Dec 15;21(24):3331-41
pubmed: 18079179
Mol Cell. 2021 Feb 4;81(3):426-441.e8
pubmed: 33545059
Dev Cell. 2021 Sep 13;56(17):2427-2439.e4
pubmed: 34352222
J Cell Biol. 2010 Jul 12;190(1):25-34
pubmed: 20624899
Mol Cell. 2020 May 21;78(4):714-724.e5
pubmed: 32353258
Genes Dev. 2000 Jun 15;14(12):1528-40
pubmed: 10859170
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell Stem Cell. 2016 Feb 4;18(2):253-61
pubmed: 26669899
Genes Dev. 2021 Aug 1;35(15-16):1079-1092
pubmed: 34266888
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Methods Enzymol. 2018;601:45-58
pubmed: 29523241
Nat Rev Mol Cell Biol. 2015 Apr;16(4):207-20
pubmed: 25714681
Dev Cell. 2017 Jun 19;41(6):638-651.e5
pubmed: 28633018
Nature. 2022 Apr;604(7904):146-151
pubmed: 35355016
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Methods Mol Biol. 2019;1896:159-190
pubmed: 30474848
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
pubmed: 7568133
J Cell Biol. 2010 Jul 12;190(1):73-87
pubmed: 20624901
EMBO Rep. 2021 Aug 4;22(8):e52032
pubmed: 34105235
Dev Cell. 2021 Sep 13;56(17):2440-2454.e6
pubmed: 34352223
Front Cell Dev Biol. 2022 Feb 21;10:838928
pubmed: 35265623
Genes Dev. 2015 Oct 1;29(19):2010-21
pubmed: 26404941
Nat Commun. 2015 Jul 06;6:7668
pubmed: 26144554
Nat Commun. 2020 Oct 20;11(1):5297
pubmed: 33082350
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Science. 2007 Aug 17;317(5840):916-24
pubmed: 17702937
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Nature. 2015 Dec 10;528(7581):286-90
pubmed: 26633632
Bioorg Med Chem Lett. 2012 Jun 1;22(11):3727-31
pubmed: 22560567
Nat Rev Mol Cell Biol. 2015 Jun;16(6):360-74
pubmed: 25999062
Nature. 2013 Feb 28;494(7438):492-496
pubmed: 23446422
Mol Cell. 2016 Dec 15;64(6):1117-1126
pubmed: 27984745
Mol Biol Cell. 2015 Apr 15;26(8):1440-51
pubmed: 25694455
Science. 2011 Aug 19;333(6045):1026-30
pubmed: 21852501
Nature. 2015 Jun 11;522(7555):179-84
pubmed: 26017310
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Cell. 2011 Jul 8;146(1):80-91
pubmed: 21729781
Nat Rev Clin Oncol. 2019 Feb;16(2):81-104
pubmed: 30356138

Auteurs

Lorenza Garribba (L)

Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.

Giuseppina De Feudis (G)

Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.

Valentino Martis (V)

Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.

Martina Galli (M)

IFOM ETS - The AIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy.

Marie Dumont (M)

Institut Curie, PSL Research University, CNRS, UMR144, Paris, France.

Yonatan Eliezer (Y)

Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

René Wardenaar (R)

European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, 9713 AV, Groningen, the Netherlands.

Marica Rosaria Ippolito (MR)

Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.

Divya Ramalingam Iyer (DR)

Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, 01605, USA.

Andréa E Tijhuis (AE)

European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, 9713 AV, Groningen, the Netherlands.

Diana C J Spierings (DCJ)

European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, 9713 AV, Groningen, the Netherlands.

Michael Schubert (M)

European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, 9713 AV, Groningen, the Netherlands.

Silvia Taglietti (S)

Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.

Chiara Soriani (C)

Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.

Simon Gemble (S)

Institut Curie, PSL Research University, CNRS, UMR144, Paris, France.

Renata Basto (R)

Institut Curie, PSL Research University, CNRS, UMR144, Paris, France.

Nick Rhind (N)

Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, MA, 01605, USA.

Floris Foijer (F)

European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, 9713 AV, Groningen, the Netherlands.

Uri Ben-David (U)

Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Daniele Fachinetti (D)

Institut Curie, PSL Research University, CNRS, UMR144, Paris, France.

Ylli Doksani (Y)

IFOM ETS - The AIRC Institute of Molecular Oncology, via Adamello 16, 20139, Milan, Italy.

Stefano Santaguida (S)

Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy. stefano.santaguida@ieo.it.
Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9/1, 20122, Milan, Italy. stefano.santaguida@ieo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH